 FLORHAM PARK, N.J., Sept. 06, 2022 GLOBE NEWSWIRE -- Celularity Inc. Nasdaq: CELU Celularity, a clinical-stage biotechnology company developing placental-derived allogeneic cell therapies, today announced that Robert Hariri, M.D., Ph.D., Founder, Chairman and Chief Executive Officer of Celularity, will participate in fireside chats at the following investor conferences: 